Tera Science KRX:073640KOSDAQ
테라사이언스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked0since Sep 11
In Q2 2026, Tera Science reported revenue of ₩3.9bn, up 6.7% year on year, and an operating loss of ₩2.1bn. Tera Science (테라사이언스) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals 4 quarters of losses Screener
Tera Science quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩3.9bn | +6.7% | −₩2.1bn margin −54.7% | – |
| Q1 2026 | ₩3.8bn | +0.0% | −₩1.7bn margin −46.6% | −₩2.0bn |
| Q4 2025 derived | ₩3.4bn | +1.6% | −₩2.0bn margin −58.8% | −₩7.3bn |
| Q3 2025 | ₩3.3bn | -12.8% | −₩2.5bn margin −76.3% | −₩2.6bn |
| Q2 2025 | ₩3.6bn | -27.3% | −₩2.6bn margin −72.1% | −₩1.7bn |
| Q1 2025 | ₩3.7bn | -26.3% | −₩3.0bn margin −79.3% | −₩5.7bn |
| Q4 2024 derived | ₩3.4bn | -38.4% | −₩2.3bn margin −68.8% | −₩423m |
| Q3 2024 | ₩3.8bn | -33.6% | −₩2.3bn margin −60.3% | −₩2.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Tera Science top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Tera Science news Korean headlines
No articles yet.